Publications by authors named "Haydn Beaton"

Claim this Profile
T
Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity.
Patrik Johansson, Karin Kaspersson, Ian K Gurrell, Elisabeth Bäck, Susanna Eketjäll, Haydn Beaton

J Med Chem· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H₁ antagonists. Part II: optimising in vivo clearance.
Mark Furber, Lilian Alcaraz, Christopher Luckhurst, Ash Bahl, Haydn Beaton

Bioorg Med Chem Lett· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H₁ antagonists. Part I.
Mark Furber, Lilian Alcaraz, Christopher Luckhurst, Ash Bahl, Haydn Beaton

Bioorg Med Chem Lett· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).
David R Cheshire, Anders Åberg, Gunilla M K Andersson, Glen Andrews, Haydn G Beaton

Bioorg Med Chem Lett· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-aminopyridines as highly selective inducible nitric oxide synthase inhibitors. Differential binding modes dependent on nitrogen substitution.
Stephen Connolly, Anders Aberg, Andrew Arvai, Haydn G Beaton, David R Cheshire

J Med Chem· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo.
Alan C Tinker, Haydn G Beaton, Nigel Boughton-Smith, Tony R Cook, Sally L Cooper

J Med Chem· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis